BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29269313)

  • 21. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
    Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE
    Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
    Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
    Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine H2-Blocker and Proton Pump Inhibitor Use and the Risk of Pneumonia in Acute Stroke: A Retrospective Analysis on Susceptible Patients.
    Arai N; Nakamizo T; Ihara H; Koide T; Nakamura A; Tabuse M; Miyazaki H
    PLoS One; 2017; 12(1):e0169300. PubMed ID: 28085910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of proton pump inhibitors and risk of ischemic events in the general population.
    Casula M; Scotti L; Galimberti F; Mozzanica F; Tragni E; Corrao G; Catapano AL
    Atherosclerosis; 2018 Oct; 277():123-129. PubMed ID: 30212680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer.
    Sharma M; Holmes HM; Mehta HB; Chen H; Aparasu RR; Shih YT; Giordano SH; Johnson ML
    Cancer; 2019 Apr; 125(7):1155-1162. PubMed ID: 30605231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study.
    Lin SM; Yang SH; Liang CC; Huang HK
    Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study.
    Lassalle M; Le Tri T; Bardou M; Biour M; Kirchgesner J; Rouby F; Dumarcet N; Zureik M; Dray-Spira R
    Eur J Clin Pharmacol; 2020 Mar; 76(3):449-457. PubMed ID: 31838548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
    Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The association between trait anger and incident stroke risk: the Atherosclerosis Risk in Communities (ARIC) Study.
    Williams JE; Nieto FJ; Sanford CP; Couper DJ; Tyroler HA
    Stroke; 2002 Jan; 33(1):13-9. PubMed ID: 11779882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proton Pump Inhibitor Use, H
    Paik JM; Rosen HN; Gordon CM; Curhan GC
    Calcif Tissue Int; 2018 Oct; 103(4):380-387. PubMed ID: 29754277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of the clopidogrel-proton pump inhibitor interaction after peripheral endovascular intervention for claudication.
    Meltzer AJ; Da Silva P; Schneider DB; Shrikhande GV
    Vasc Endovascular Surg; 2012 Oct; 46(7):524-9. PubMed ID: 22989428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
    Li ZH; Zhong WF; Qiu CS; Yang P; Song WQ; Shen D; Zhang XR; Liu D; Chen YJ; Chen PL; Huang QM; Chen Q; Wang XM; Chung VCH; Gao X; Kraus VB; Liu SD; Mao C
    Int J Cardiol; 2024 Jan; 395():131567. PubMed ID: 37935336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.
    Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L;
    Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of long-term gastric acid suppression on spontaneous bacterial peritonitis in patients with advanced decompensated liver cirrhosis.
    Huang KW; Kuan YC; Luo JC; Lin CL; Liang JA; Kao CH
    Eur J Intern Med; 2016 Jul; 32():91-5. PubMed ID: 27139916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple Silent Lacunes Are Associated with Recurrent Ischemic Stroke.
    Andersen SD; Skjøth F; Yavarian Y; Bach FW; Lip GY; Larsen TB
    Cerebrovasc Dis; 2016; 42(1-2):73-80. PubMed ID: 27070721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Risks of Ischemic Stroke in Atrial Flutter versus Atrial Fibrillation.
    Al-Kawaz M; Omran SS; Parikh NS; Elkind MSV; Soliman EZ; Kamel H
    J Stroke Cerebrovasc Dis; 2018 Apr; 27(4):839-844. PubMed ID: 29223550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent use of Chinese herbal medicine among hormone users and its association with ischemic stroke risk: A population-based study.
    Wen SH; Chang WC; Hong MK; Wu HC
    J Ethnopharmacol; 2018 Apr; 216():274-282. PubMed ID: 29366767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies.
    Yuan J; He Q; Nguyen LH; Wong MCS; Huang J; Yu Y; Xia B; Tang Y; He Y; Zhang C
    Gut; 2021 Jun; 70(6):1070-1077. PubMed ID: 32989021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry.
    Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.